Invention Grant
- Patent Title: Non-selective kinase inhibitors
-
Application No.: US16273878Application Date: 2019-02-12
-
Publication No.: US10532994B2Publication Date: 2020-01-14
- Inventor: Lawrence S Zisman
- Applicant: Pulmokine, Inc. , GILEAD SCIENCES, INC.
- Applicant Address: US NY Rensselaer US CA Foster City
- Assignee: PULMOKINE, INC.,GILEAD SCIENCES, INC.
- Current Assignee: PULMOKINE, INC.,GILEAD SCIENCES, INC.
- Current Assignee Address: US NY Rensselaer US CA Foster City
- Agency: Seed IP Law Group LLP
- Main IPC: C07D401/12
- IPC: C07D401/12 ; C07D241/20 ; C07D403/12 ; A61K31/4965
Abstract:
Disclosed herein are compounds, compositions, and methods for preventing and treating proliferative diseases associated with aberrant receptor tyrosine kinase (RTK) activity. The therapeutic indications described herein more specifically relate to the non-selective inhibition of RTKs associated with vascular and pulmonary disorders.
Public/Granted literature
- US20190248761A1 NON-SELECTIVE KINASE INHIBITORS Public/Granted day:2019-08-15
Information query
